United States Non-Small Cell Lung Cancer Market Size, Share, and Forecast Through 2034
The United States represents the largest contributor to the NSCLC market due to its extensive oncology care network, strong clinical research ecosystem, and high healthcare expenditure. The country continues to witness significant advancements in targeted therapies aimed at specific genetic mutations such as EGFR, ALK, ROS1, and KRAS. Increased utilization of immunotherapy drugs and combination...
0 التعليقات 0 المشاركات 305 مشاهدة 0 معاينة
FrendVibe https://frendvibe.com